Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Sep 2023. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 12554741000202118 | Product containing precisely ledipasvir 45 milligram and sofosbuvir 200 milligram/1 sachet conventional release oral granules (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 13302581000202111 | Ledipasvir 45 mg and sofosbuvir 200 mg oral granules sachet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely ledipasvir 45 milligram and sofosbuvir 200 milligram/1 sachet conventional release oral granules (clinical drug) | Is a | Product containing only ledipasvir and sofosbuvir in oral dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Product containing precisely ledipasvir 45 milligram and sofosbuvir 200 milligram/1 sachet conventional release oral granules (clinical drug) | Has manufactured dose form | Oral granules | true | Inferred relationship | Some | ||
| Product containing precisely ledipasvir 45 milligram and sofosbuvir 200 milligram/1 sachet conventional release oral granules (clinical drug) | Has unit of presentation | Sachet (unit of presentation) | true | Inferred relationship | Some | ||
| Product containing precisely ledipasvir 45 milligram and sofosbuvir 200 milligram/1 sachet conventional release oral granules (clinical drug) | Plays role | Antiviral therapeutic role | true | Inferred relationship | Some | ||
| Product containing precisely ledipasvir 45 milligram and sofosbuvir 200 milligram/1 sachet conventional release oral granules (clinical drug) | Has precise active ingredient | Sofosbuvir (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely ledipasvir 45 milligram and sofosbuvir 200 milligram/1 sachet conventional release oral granules (clinical drug) | Has basis of strength substance (attribute) | Sofosbuvir (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely ledipasvir 45 milligram and sofosbuvir 200 milligram/1 sachet conventional release oral granules (clinical drug) | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Product containing precisely ledipasvir 45 milligram and sofosbuvir 200 milligram/1 sachet conventional release oral granules (clinical drug) | Has presentation strength denominator unit (attribute) | Sachet (unit of presentation) | true | Inferred relationship | Some | 1 | |
| Product containing precisely ledipasvir 45 milligram and sofosbuvir 200 milligram/1 sachet conventional release oral granules (clinical drug) | Has precise active ingredient | Ledipasvir (substance) | true | Inferred relationship | Some | 2 | |
| Product containing precisely ledipasvir 45 milligram and sofosbuvir 200 milligram/1 sachet conventional release oral granules (clinical drug) | Has basis of strength substance (attribute) | Ledipasvir (substance) | true | Inferred relationship | Some | 2 | |
| Product containing precisely ledipasvir 45 milligram and sofosbuvir 200 milligram/1 sachet conventional release oral granules (clinical drug) | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
| Product containing precisely ledipasvir 45 milligram and sofosbuvir 200 milligram/1 sachet conventional release oral granules (clinical drug) | Has presentation strength denominator unit (attribute) | Sachet (unit of presentation) | true | Inferred relationship | Some | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR